Cargando…

Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia—A Case Series and Review of the Literature

Introduction: Factor VII (FVII) deficiency is a rare hemorrhagic diathesis. In females, heavy menstrual and postpartum bleeding can appear as a consequence of its deficiency. Supplementation of the recombinant FVIIa is widely accepted. The supplementation effect in FVII-deficient subjects is difficu...

Descripción completa

Detalles Bibliográficos
Autores principales: Krzyżanowski, Arkadiusz, Gęca, Tomasz, Sokołowska, Bożena, Kwiatek, Maciej, Miturski, Andrzej, Stupak, Aleksandra, Terlecki, Piotr, Paluszkiewicz, Piotr, Kwaśniewska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518547/
https://www.ncbi.nlm.nih.gov/pubmed/36078653
http://dx.doi.org/10.3390/ijerph191710918
_version_ 1784799210175987712
author Krzyżanowski, Arkadiusz
Gęca, Tomasz
Sokołowska, Bożena
Kwiatek, Maciej
Miturski, Andrzej
Stupak, Aleksandra
Terlecki, Piotr
Paluszkiewicz, Piotr
Kwaśniewska, Anna
author_facet Krzyżanowski, Arkadiusz
Gęca, Tomasz
Sokołowska, Bożena
Kwiatek, Maciej
Miturski, Andrzej
Stupak, Aleksandra
Terlecki, Piotr
Paluszkiewicz, Piotr
Kwaśniewska, Anna
author_sort Krzyżanowski, Arkadiusz
collection PubMed
description Introduction: Factor VII (FVII) deficiency is a rare hemorrhagic diathesis. In females, heavy menstrual and postpartum bleeding can appear as a consequence of its deficiency. Supplementation of the recombinant FVIIa is widely accepted. The supplementation effect in FVII-deficient subjects is difficult to predict, and severe hemorrhage has been described even when FVII levels after supplementation were within normal ranges. The aim of this report is to present the application of thromboelastometry to control the coagulation status in a patient with severe FVII deficiency during pregnancy and delivery, supplemented by rFVIIa per protocol complicated with life-threatening venous thromboembolism. Methods: Rotational thromboelastometry (ROTEM) was performed in 16 pregnant women: in one 28 year old primigravida at 35 weeks of pregnancy with congenital FVII deficiency after rFVIIa administration and 15 healthy women at 38 gestational weeks. The results were compared. Results: The thromboelastometry results showed significant shortening of the clotting time in the extrinsic and the intrinsic pathway in the hypoproconvertinemia patient after rFVIIa administration in relation to healthy pregnant women. A significant reduction in maximum lysis of the clot after FVII supplementation was observed. Conclusions: The thromboelastometry results showed a significant hypercoagulable state with hypoproconvertinemia. Thrombotic complications after delivery might be prevented by the reduction in rFVIIa guided by thromboelastometry. Thromboelastometry performed on a pregnant woman with factor VII deficiency during the supplementation of rFVIIa in peripartum time might be helpful in order to determine an individual, effective dosage regimen of rFVIIa to ensure full correction of clotting disorders without the tendency to develop thrombosis, but further studies are needed.
format Online
Article
Text
id pubmed-9518547
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95185472022-09-29 Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia—A Case Series and Review of the Literature Krzyżanowski, Arkadiusz Gęca, Tomasz Sokołowska, Bożena Kwiatek, Maciej Miturski, Andrzej Stupak, Aleksandra Terlecki, Piotr Paluszkiewicz, Piotr Kwaśniewska, Anna Int J Environ Res Public Health Article Introduction: Factor VII (FVII) deficiency is a rare hemorrhagic diathesis. In females, heavy menstrual and postpartum bleeding can appear as a consequence of its deficiency. Supplementation of the recombinant FVIIa is widely accepted. The supplementation effect in FVII-deficient subjects is difficult to predict, and severe hemorrhage has been described even when FVII levels after supplementation were within normal ranges. The aim of this report is to present the application of thromboelastometry to control the coagulation status in a patient with severe FVII deficiency during pregnancy and delivery, supplemented by rFVIIa per protocol complicated with life-threatening venous thromboembolism. Methods: Rotational thromboelastometry (ROTEM) was performed in 16 pregnant women: in one 28 year old primigravida at 35 weeks of pregnancy with congenital FVII deficiency after rFVIIa administration and 15 healthy women at 38 gestational weeks. The results were compared. Results: The thromboelastometry results showed significant shortening of the clotting time in the extrinsic and the intrinsic pathway in the hypoproconvertinemia patient after rFVIIa administration in relation to healthy pregnant women. A significant reduction in maximum lysis of the clot after FVII supplementation was observed. Conclusions: The thromboelastometry results showed a significant hypercoagulable state with hypoproconvertinemia. Thrombotic complications after delivery might be prevented by the reduction in rFVIIa guided by thromboelastometry. Thromboelastometry performed on a pregnant woman with factor VII deficiency during the supplementation of rFVIIa in peripartum time might be helpful in order to determine an individual, effective dosage regimen of rFVIIa to ensure full correction of clotting disorders without the tendency to develop thrombosis, but further studies are needed. MDPI 2022-09-01 /pmc/articles/PMC9518547/ /pubmed/36078653 http://dx.doi.org/10.3390/ijerph191710918 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Krzyżanowski, Arkadiusz
Gęca, Tomasz
Sokołowska, Bożena
Kwiatek, Maciej
Miturski, Andrzej
Stupak, Aleksandra
Terlecki, Piotr
Paluszkiewicz, Piotr
Kwaśniewska, Anna
Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia—A Case Series and Review of the Literature
title Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia—A Case Series and Review of the Literature
title_full Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia—A Case Series and Review of the Literature
title_fullStr Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia—A Case Series and Review of the Literature
title_full_unstemmed Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia—A Case Series and Review of the Literature
title_short Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia—A Case Series and Review of the Literature
title_sort thromboelastometry as an ancillary tool for evaluation of coagulation status after rfviia therapy in a pregnant woman with severe hypoproconvertinemia—a case series and review of the literature
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518547/
https://www.ncbi.nlm.nih.gov/pubmed/36078653
http://dx.doi.org/10.3390/ijerph191710918
work_keys_str_mv AT krzyzanowskiarkadiusz thromboelastometryasanancillarytoolforevaluationofcoagulationstatusafterrfviiatherapyinapregnantwomanwithseverehypoproconvertinemiaacaseseriesandreviewoftheliterature
AT gecatomasz thromboelastometryasanancillarytoolforevaluationofcoagulationstatusafterrfviiatherapyinapregnantwomanwithseverehypoproconvertinemiaacaseseriesandreviewoftheliterature
AT sokołowskabozena thromboelastometryasanancillarytoolforevaluationofcoagulationstatusafterrfviiatherapyinapregnantwomanwithseverehypoproconvertinemiaacaseseriesandreviewoftheliterature
AT kwiatekmaciej thromboelastometryasanancillarytoolforevaluationofcoagulationstatusafterrfviiatherapyinapregnantwomanwithseverehypoproconvertinemiaacaseseriesandreviewoftheliterature
AT miturskiandrzej thromboelastometryasanancillarytoolforevaluationofcoagulationstatusafterrfviiatherapyinapregnantwomanwithseverehypoproconvertinemiaacaseseriesandreviewoftheliterature
AT stupakaleksandra thromboelastometryasanancillarytoolforevaluationofcoagulationstatusafterrfviiatherapyinapregnantwomanwithseverehypoproconvertinemiaacaseseriesandreviewoftheliterature
AT terleckipiotr thromboelastometryasanancillarytoolforevaluationofcoagulationstatusafterrfviiatherapyinapregnantwomanwithseverehypoproconvertinemiaacaseseriesandreviewoftheliterature
AT paluszkiewiczpiotr thromboelastometryasanancillarytoolforevaluationofcoagulationstatusafterrfviiatherapyinapregnantwomanwithseverehypoproconvertinemiaacaseseriesandreviewoftheliterature
AT kwasniewskaanna thromboelastometryasanancillarytoolforevaluationofcoagulationstatusafterrfviiatherapyinapregnantwomanwithseverehypoproconvertinemiaacaseseriesandreviewoftheliterature